U.S. Retail Distributors Stock News

AerCap Holdings (NYSE:AER) and Frontier Group Holdings agreed to the early return of 24 A320neo aircraft, with the process expected to complete by Q2 2026. AerCap is also set to participate in 10 future sale leaseback transactions with Frontier for aircraft scheduled to be delivered in 2028 and 2029. The agreement adjusts AerCap's medium term fleet and lease commitments, while reshaping its relationship with a key US low cost carrier customer. AerCap is one of the largest aircraft leasing...

Earlier this week, Bruker Corporation unveiled major upgrades across its spatial biology and proteomics portfolio, including the PaintScape 3D genome visualization platform, the CellScape XR spatial proteomics system, Functional Proteomics 2.0 workflows on timsOmni, and a new Spatial Biology Center of Excellence with the University of Glasgow. Together, these launches and collaborations deepen Bruker’s presence in high-content multiomics and translational research tools, potentially...

AT&T has secured new spectrum licenses and fiber assets, expanding its network footprint. The company has been recognized as the first recipient of Ookla's "Best Home Internet" award for AT&T Fiber. These developments come as AT&T (NYSE:T) trades at a share price of $28.52. For investors watching NYSE:T, the combination of new spectrum and fiber assets with third party recognition for home internet performance adds fresh context to the current share price of $28.52. Over the past month, the...

In February 2026, Belden Inc. reported past fourth-quarter 2025 sales of US$720.12 million and net income of US$67.89 million, alongside full-year 2025 sales of US$2.72 billion and net income of US$237.52 million, while outlining first-quarter 2026 guidance and confirming continued share repurchases. The combination of higher earnings, ongoing buybacks totaling US$154.91 million for 1.35 million shares, and an active M&A agenda underlines Belden’s focus on long-term value creation. With...

Everpure stock performance context Without a single headline event driving sentiment, Everpure (PSTG) has still seen meaningful price swings, including a 7.4% decline over the past day and 7.3% over the past week. See our latest analysis for Everpure. That recent 7.4% one day share price decline and 7.3% 7 day share price pullback sit against a softer 30 day share price return of a 1.9% decline and a much stronger 3 year total shareholder return of about 139%, suggesting long term momentum...

Why CMS Energy (CMS) is on investors’ radar today CMS Energy (CMS) has not been driven by a single headline event recently, but its recent share performance and fundamentals give investors several concrete data points to weigh. The stock’s recent returns span a mixed short term picture and a stronger longer term track record. CMS is up 0.6% over the past day, has slipped about 0.6% over the past week, and is higher by 7.9% over the past month. Looking further out, the total return stands at...

FMC (FMC) is at a turning point after reporting sharp sales declines tied to its exit from India, ongoing earnings pressures and leadership changes, while also weighing a potential sale and pursuing US$1b in asset sales and licensing. See our latest analysis for FMC. The latest updates come after a sharp reset in FMC’s share price, with a 1 year total shareholder return decline of 62.16% and a 5 year total shareholder return decline of 85.02%. Recent 30 day share price pressure contrasts with...

In February 2026, Rumble Inc. announced that its short-form video feature, Rumble Shorts, had been approved by Google Play, allowing Android users worldwide to download or update the app to access the new format. This move extends Rumble's short-form offering to a larger mobile audience while aiming to maintain the platform's freedom-first positioning in an increasingly competitive video landscape. Now we'll examine how expanding Rumble Shorts to Android users could influence Rumble's...

Telephone and Data Systems, Inc. reported past fourth-quarter 2025 results with revenue of US$330.71 million and net income of US$56.47 million, alongside declaring first-quarter 2026 common and preferred dividends payable on March 31, 2026. The company also completed a multi-year buyback program totaling 9,418,555 shares for US$226.07 million, which, combined with improved quarterly profitability, signals an emphasis on capital returns and balance sheet management. We will now examine how...

In recent weeks, Five Below has continued its expansion by opening a new store at Route 6 Mall near Honesdale and planning to occupy a former Jo-Ann Fabrics space in Sahuarita, while rolling out low-priced seasonal merchandise such as Easter items, outdoor gear, and trend-led products like a US$20 pet carrier and a US$5 edition of Wuthering Heights. Together with analysts’ expectation that a recent Supreme Court tariff ruling could ease cost pressures on Chinese imports, these moves...

Navigator Holdings (NVGS) has drawn investor attention recently, with the share price at $19.80 and total return figures over the past year and the past 3 months providing a clearer picture of its recent trading performance. See our latest analysis for Navigator Holdings. The recent 30 day share price return of 7.67% and 90 day share price return of 11.30%, alongside a 1 year total shareholder return of 27.83%, suggests momentum has been building over both shorter and longer horizons. If this...

Tyra Biosciences recently announced that two clinical abstracts on its precision FGFR3 inhibitor TYRA-300 in metastatic urothelial cancer and non-muscle invasive bladder cancer were accepted for presentation at the 2026 ASCO Genitourinary Cancers Symposium. This acceptance highlights growing clinical and scientific interest in TYRA-300’s potential role across distinct bladder cancer settings, a central pillar of Tyra’s pipeline. Against this backdrop, we’ll explore how TYRA-300’s ASCO GU...

Procore Technologies (PCOR) is back in focus after its Q4 2025 earnings and 2026 revenue guidance, with investors weighing solid sales growth, a smaller net loss, and early traction from the company’s AI initiatives. See our latest analysis for Procore Technologies. The share price has pulled back sharply, with a 30 day share price return of 25.56% decline and a 1 year total shareholder return of 39.25% decline. This suggests that recent enthusiasm around earnings and AI adoption is being...

Rollins, Inc. recently reported higher fourth-quarter and full-year 2025 earnings, continued to signal a healthy M&A pipeline, and earlier this month presented its outlook at Barclays’ 43rd Annual Industrial Select Conference in Miami. Management’s emphasis on recurring revenue, disciplined acquisitions, and confidence in funding further deals after investing almost US$900 million over three years highlights how central M&A has become to Rollins’ growth ambitions. We’ll now examine how...

In February 2026, Franklin Electric Co., Inc. reported Q4 and full-year 2025 results showing higher quarterly sales and earnings per share than the prior year, alongside full-year 2025 sales of US$2.13 billion and net income of US$147.09 million, and issued 2026 sales guidance of US$2.17 billion to US$2.24 billion. Beyond the headline figures, the combination of record annual sales, lower full-year net income, and modest 2026 growth guidance highlights the tension between expansion...

Plexus overview after recent trading move Plexus (PLXS) has drawn fresh attention after a recent move in its share price, with the stock last closing at $197.55. That level reflects a 1 day return of about a 0.5% decline and a 7 day return of roughly a 1.9% decline. See our latest analysis for Plexus. While Plexus has seen a modest 1 day share price pullback and a softer 7 day share price return, the 30 day share price return of 13.52% and 90 day share price return of 38.52% sit alongside a 1...

Neurocrine Biosciences (NBIX) is back in focus after reporting fourth quarter and full year 2025 earnings, alongside fresh 2026 sales guidance for INGREZZA and optimistic commentary around its late stage pipeline. See our latest analysis for Neurocrine Biosciences. At a latest share price of US$128.38, Neurocrine Biosciences has seen short term share price pressure, with a 30 day share price return of a 5.73% decline and a 90 day share price return of a 10.56% decline. However, a 1 year total...

Recent filings show Battery Management Corp. and Solel Partners LP expanding their positions in Braze (BRZE), even after a sharp share price pullback. This puts institutional behavior in focus for anyone tracking the stock. See our latest analysis for Braze. At a latest share price of $15.79, Braze has seen a sharp reset, with a 30 day share price return of a 37.14% decline and a 1 year total shareholder return of a 59% loss, indicating momentum that has been fading even as revenue and...

Johnson & Johnson (JNJ) has packed several clinically focused announcements into February, including new subcutaneous dosing approvals for RYBREVANT, long term TREMFYA data in ulcerative colitis, and a more than US$1b U.S. cell therapy manufacturing build out. See our latest analysis for Johnson & Johnson. All these February announcements around RYBREVANT, TREMFYA and new U.S. manufacturing capacity are landing at a time when momentum in Johnson & Johnson’s shares is strong, with an 11.7% 1...

Why ICU Medical is back on investors’ radar ICU Medical (ICUI) has moved back into focus after resolving a longstanding FDA warning letter tied to its Smiths Medical business and posting fourth quarter results with adjusted earnings above analyst expectations, along with 2026 guidance that came in ahead of consensus. The company paired these updates with detailed 2026 earnings guidance, giving investors clearer visibility into expected GAAP net income of US$26 million to US$44 million and...

CVR Energy stock snapshot after recent performance CVR Energy (CVI) has been on many investors’ radars after a mixed run, with the share price up about 1.7% over the past day but showing weaker returns across the past week and month. At a last close of US$21.07, CVR Energy sits below its past 3 months level, with the stock also reflecting a negative year to date return and a weaker 3 year total return. See our latest analysis for CVR Energy. The recent 1 day share price gain contrasts with...

Applied Optoelectronics (AAOI) shares have been in focus after a run to nine year highs, with investors reacting to a cluster of events around earnings, new data center products, and fresh manufacturing capacity. See our latest analysis for Applied Optoelectronics. The recent run has been sharp, with a 51.06% 1 month share price return and a 137.40% 3 month share price return as investors react to earnings anticipation, new AI focused data center products, and the Texas capacity expansion...

Archer Aviation has opened a new UK Engineering Hub in Bristol and announced plans to integrate NVIDIA’s IGX Thor platform into future aircraft to support advanced AI for safety-critical and autonomy-ready flight systems, including work tied to defense collaborations in the UK and with Anduril. By pairing an aerospace-focused talent base in Bristol with NVIDIA’s aviation AI technology, Archer is trying to deepen both its commercial air-taxi and defense technology capabilities across multiple...

On 17 February 2026, Bernstein Litowitz Berger & Grossmann LLP filed a class action alleging that Express Scripts, Cigna, and Evernorth diverted billions in drug rebates to a Swiss affiliate, Ascent, using disguised “fees” and formulary decisions that allegedly favored higher-paying drug manufacturers over lower-cost alternatives. The lawsuit directly challenges how Express Scripts and its parent Cigna structure and disclose PBM rebate economics, raising complex questions about fiduciary...